Article
An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: protocol
2024-06-17
Abstract excerpt
Valproate is the most effective treatment for idiopathic generalised epilepsy. Currently, its use is restricted in women of childbearing potential owing to high teratogenicity. Recent evidence extended this risk to men’s offspring, prompting recommendations to restrict use in everybody aged <55 years. This study will evaluate mortality and morbidity risks associated with valproate withdrawal by emulating a hypothe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e94d9d7-31bb-5fc0-8262-2f247678ada0
- DOI
- 10.1101/2024.06.16.24308993
